Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: TearCare MGX™ System With and Without Warming Hold [NA]

View source ↗

Summary

Clinical trial update for the TearCare MGX System evaluating with and without warming hold for meibomian gland dysfunction; the study status is ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TearCare MGX System

Snippet

Sponsor: Sight Sciences, Inc. | Conditions: Meibomian Gland Dysfunction (Disorder) | NA | Status: ACTIVE_NOT_RECRUITING